These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26579)

  • 21. [Effects of psychotropic drugs and the roles of the noradrenergic and dopaminergic systems in the lateral hypothalamic self-stimulation behavior].
    Hasegawa K; Sakai U
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):815-26. PubMed ID: 1035185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cataleptic action of nitrazepam and brain dopamine function in mice.
    Matsui Y; Deguchi T
    Neuropharmacology; 1977 Apr; 16(4):253-8. PubMed ID: 140329
    [No Abstract]   [Full Text] [Related]  

  • 23. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
    Guldberg HC; Yates CM
    Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical pharmacology of paradoxical sleep.
    Gaillard JM
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):205S-230S. PubMed ID: 6140943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of some dopamine-beta-hydroxylase inhibitors on the control mechanisms of the estrous cycle in rats.
    Kun I
    Endocrinologie; 1978; 16(4):263-8. PubMed ID: 569899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine-beta-hydroxylase inhibitors modulate the concentration of functional estrogen receptors in female rat hypothalamus and pituitary gland.
    Blaustein JD; Brown TJ; Swearengen ES
    Neuroendocrinology; 1986; 43(2):150-8. PubMed ID: 3014364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atropine effects on the intermediate stage and paradoxical sleep in rats.
    Arnaud C; Gauthier P; Gottesmann C
    Psychopharmacology (Berl); 1994 Nov; 116(3):304-8. PubMed ID: 7892420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the dopamine-beta-hydroxylase inhibitor FLA 63 on the kinetics of elimination of amphetamine in the rat.
    Jonsson J; Lewander T
    J Pharm Pharmacol; 1974 Nov; 26(11):907-9. PubMed ID: 4156566
    [No Abstract]   [Full Text] [Related]  

  • 30. Paradoxical effects in sleep and performance of two doses of chlorpromazine.
    Hartley L; Couper-Smartt J
    Psychopharmacology (Berl); 1978 Jul; 58(2):201-5. PubMed ID: 210476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract]   [Full Text] [Related]  

  • 32. Diurnal rhythm in the central dopamine turnover in the rat.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):257-61. PubMed ID: 567283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal variations in the motor activity of the rat: effects of inhibitors of the catecholamine synthesis.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):251-6. PubMed ID: 567282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the role of brain alpha-adrenergic systems in the production of paradoxical sleep.
    Gaillard JM; Kafi S; Justafre JC
    Encephale; 1982; 8(3):413-34. PubMed ID: 6311511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of neuroleptics on endogenous norepinephrine in rat brain.
    Bartholini G; Keller HH; Pletscher A
    Neuropharmacology; 1973 Aug; 12(8):751-6. PubMed ID: 4746440
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 39. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 40. Morphine lethality in rats: effects of inhibitors of brain catecholamine synthesis and methylation.
    Davis WM; Khalsa JH
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):867-72. PubMed ID: 4148579
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.